MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

EVOO and Metabolic Liver Health in MASLD

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

Identification and Characterization of At-risk MASLD in Turkish Adults

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Accurate Point of Care Liver Disease Diagnostics (Phase 2)

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Exercise for an Aging Liver (EXALIVER)

Spleen Stiffness Measurement for the Detection of Advanced Fibrosis

Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH

Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve Long-term Clinical Outcomes in MASLD

Duodenal ReCET for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease

Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity

Quantitative Ultrasound to Assess Steatotic Liver Disease in Children

Screening and Intervention of MASLD in Children

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD